BR112015012138A2 - composição, método para obtenção de uma composição, método de formação de imagem in vivo, e, kit - Google Patents

composição, método para obtenção de uma composição, método de formação de imagem in vivo, e, kit

Info

Publication number
BR112015012138A2
BR112015012138A2 BR112015012138A BR112015012138A BR112015012138A2 BR 112015012138 A2 BR112015012138 A2 BR 112015012138A2 BR 112015012138 A BR112015012138 A BR 112015012138A BR 112015012138 A BR112015012138 A BR 112015012138A BR 112015012138 A2 BR112015012138 A2 BR 112015012138A2
Authority
BR
Brazil
Prior art keywords
composition
kit
obtaining
vivo imaging
vivo
Prior art date
Application number
BR112015012138A
Other languages
English (en)
Portuguese (pt)
Inventor
Mohammed Kadavilpparampu Mohamed Afsal
Nilsen Sondre
Balaji Aralikatti Prahladachar Balaji Srinath
P Mokkapati Umamaheshwar
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1300647.3A external-priority patent/GB201300647D0/en
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of BR112015012138A2 publication Critical patent/BR112015012138A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
BR112015012138A 2012-11-30 2013-11-28 composição, método para obtenção de uma composição, método de formação de imagem in vivo, e, kit BR112015012138A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3689DE2012 2012-11-30
GBGB1300647.3A GB201300647D0 (en) 2013-01-15 2013-01-15 Crystallization
PCT/EP2013/074986 WO2014083113A1 (en) 2012-11-30 2013-11-28 Crystallization process of tricyclic indole derivatives

Publications (1)

Publication Number Publication Date
BR112015012138A2 true BR112015012138A2 (pt) 2017-07-11

Family

ID=54266915

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015012138A BR112015012138A2 (pt) 2012-11-30 2013-11-28 composição, método para obtenção de uma composição, método de formação de imagem in vivo, e, kit

Country Status (12)

Country Link
US (1) US10709798B2 (cg-RX-API-DMAC7.html)
EP (1) EP2943195A1 (cg-RX-API-DMAC7.html)
JP (1) JP6280560B2 (cg-RX-API-DMAC7.html)
KR (1) KR20150088802A (cg-RX-API-DMAC7.html)
CN (2) CN104837489A (cg-RX-API-DMAC7.html)
AU (1) AU2013351152A1 (cg-RX-API-DMAC7.html)
BR (1) BR112015012138A2 (cg-RX-API-DMAC7.html)
CA (1) CA2892485A1 (cg-RX-API-DMAC7.html)
IN (1) IN2015DN03978A (cg-RX-API-DMAC7.html)
MX (1) MX2015006871A (cg-RX-API-DMAC7.html)
RU (1) RU2015118217A (cg-RX-API-DMAC7.html)
WO (1) WO2014083113A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2015118217A (ru) 2012-11-30 2017-01-11 ДжиИ ХЕЛТКЕР ЛИМИТЕД Способ кристаллизации трициклических индольных производных
US20160144477A1 (en) * 2014-11-21 2016-05-26 Diane Scott Coated compressive subpad for chemical mechanical polishing

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177440B1 (en) * 1996-10-30 2001-01-23 Eli Lilly And Company Substituted tricyclics
JP2001522884A (ja) 1997-11-14 2001-11-20 イーライ・リリー・アンド・カンパニー アルツハイマー病の処置方法
DZ2769A1 (fr) 1998-04-17 2003-12-01 Lilly Co Eli Composés tricycliques substitués.
JP2005527464A (ja) 2001-08-09 2005-09-15 イーライ・リリー・アンド・カンパニー ｓＰＬＡ２インヒビターとしてのシクロヘプタＢインドール誘導体
JP2005527466A (ja) 2001-08-09 2005-09-15 イーライ・リリー・アンド・カンパニー ｓＰＬＡ２インヒビターとしてのシクロヘプトＢインドール誘導体
GB0905328D0 (en) * 2009-03-27 2009-05-13 Ge Healthcare Ltd Indole derivatives
CN102834379B (zh) 2010-03-26 2014-12-24 通用电气健康护理有限公司 作为pbr配体的三环吲哚衍生物
GB201016038D0 (en) 2010-09-24 2010-11-10 Ge Healthcare Ltd In vivo imaging method
GB201016411D0 (en) 2010-09-30 2010-11-10 Ge Healthcare Ltd In vivo imaging method for cancer
GB201021263D0 (en) 2010-12-15 2011-01-26 Ge Healthcare Ltd Solid phase extraction method
US9220795B2 (en) * 2011-09-22 2015-12-29 Ge Healthcare Limited Indole derivatives
RU2015118217A (ru) 2012-11-30 2017-01-11 ДжиИ ХЕЛТКЕР ЛИМИТЕД Способ кристаллизации трициклических индольных производных

Also Published As

Publication number Publication date
MX2015006871A (es) 2015-09-16
CN104837489A (zh) 2015-08-12
IN2015DN03978A (cg-RX-API-DMAC7.html) 2015-10-02
US20150335766A1 (en) 2015-11-26
JP2016507477A (ja) 2016-03-10
CN111362863A (zh) 2020-07-03
AU2013351152A1 (en) 2015-05-21
EP2943195A1 (en) 2015-11-18
US10709798B2 (en) 2020-07-14
CA2892485A1 (en) 2014-06-05
JP6280560B2 (ja) 2018-02-14
WO2014083113A1 (en) 2014-06-05
RU2015118217A (ru) 2017-01-11
KR20150088802A (ko) 2015-08-03

Similar Documents

Publication Publication Date Title
MX2023006541A (es) Formulaciones de dosis fija.
BR112015022047A8 (pt) uso de uma composição compreendendo nanopartículas contendo um fármaco da família limo e uma albumina
CO6630147A2 (es) Modificador del sabor dulce
MX348823B (es) Formulaciones estables de linaclotida.
MY157124A (en) Substituted imidazopyridinyl-aminopyridine compounds
PH12012501337A1 (en) Substituted pyrrolo-aminopyrimidine compounds
MX2015008628A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
BR112013007364A2 (pt) preparação para melhorar a solubilidade para um fármaco pouco solúvel
PH12013502565A1 (en) Substituted imidazopyridinyl-aminopyridine compounds
NZ708824A (en) Tetracycline topical formulations, preparation and uses thereof
MX2011006959A (es) Compuestos substituidos de 5,6-dihidro-6-fenilbenzo [f] isoquinolina-2-amina.
WO2011082267A3 (en) Substituted triazolo-pyrazine compounds
MX2012001660A (es) Formulaciones que contienen linaclotida para adminstracion oral.
MX2013001234A (es) Derivados deuterados de tandospirona como agonistas del receptor 5-hidroxitriptamina 1a.
WO2013188283A8 (en) Topical ophthalmological pharmaceutical composition containing sunitinib
WO2015033302A3 (en) Fulvestrant compositions
MA37610A1 (fr) Formulations de testostérone proliposomales
BR112015004523A2 (pt) compostos de tetraciclina
MX2012001691A (es) Composiciones de linaclotida que se desintegran oralmente.
PH12012501556A1 (en) Substituted naphthalenyl-pyrimidine compounds
EA201490363A1 (ru) Новые составы на основе (триметоксифениламино)пиримидинилов
TN2015000280A1 (en) Topical Ophthalmological Pharmaceutical Composition containing Regorafenib
CA2922375C (en) Alpha-tea salt forms: compositions and uses for treating disease
BR112014032254A2 (pt) processo para a preparação de uma composição, aparelho, e, uso de um aparelho
WO2014006635A3 (en) Solid oral compositions of silodosin

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]